TxCell
Latest round
- Series C
Last raised
- Oct 2012
Total raised
- $25M
Investors
- 7
About TxCell
A.A. develops innovative immunotherapies aimed at treating chronic diseases. The company has not undergone significant strategic pivots and does not have known subsidiaries.TxCell specializes in advanced cell therapy solutions, primarily focusing on the development of personalized immunotherapies for patients with chronic diseases. Their core product offerings include T-cell immunotherapies designed to treat specific types of cancer and autoimmune diseases, leveraging the patient's immune system to target diseased cells. These therapies utilize proprietary technology to enhance T-cell specificity and efficacy, aiming to improve patient outcomes for conditions such as multiple sclerosis and various hematological malignancies.TxCell generates revenue through B2B partnerships with healthcare providers and pharmaceutical companies, primarily from licensing agreements for its proprietary technologies and therapeutic products. Revenue streams include milestone payments tied to clinical development phases and royalties on future product sales. TxCell's premium-priced flagship products reflect their innovative nature and the significant value they bring to chronic disease treatment protocols. The company is targeting new markets, particularly in North America and Europe, by 2015 to capture growing demand for its advanced therapies.2 mn.
Who invested in TxCell
7 investors across 2 rounds
See all investors in TxCell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TxCell
Who invested in TxCell?
TxCell has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TxCell raised?
TxCell has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TxCell last raise money?
TxCell's most recent round on record is a Series C, in Oct 2012.
What does TxCell do?
TxCell is a biotechnology company.
Where is TxCell headquartered?
TxCell is headquartered in France.
Which VCs invest in companies like TxCell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at TxCell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like TxCell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.